Copyright © 2004 by the European Society of Cardiology.
Clinical research
Prevalence and prognosis of subjects with Brugada-type ECG pattern in a young and middle-aged Finnish population
a Department of Internal Medicine, Division of Cardiology, University of Oulu, P.O. Box 5000, 90014 Oulu, Finland
b Central Military Hospital, Helsinki, Finland
* Corresponding author. Tel.: +358-83154447; fax: +358-83155599
E-mail address: mattiju{at}mail.student.oulu.fi
Received 30 September 2003; revised 10 December 2003; accepted 13 January 2004 See page 810 for the editorial comment on this article.1
Abstract
Aims The purpose of this study was (1) to determine the prevalence of Brugada syndrome ECG abnormalities ("Brugada sign") in two Finnish populations and (2) to evaluate the natural course of subjects with the "Brugada sign".
Methods and results The study population consisted of 2479 healthy male Air Force applicants (age 1830 years), and 542 healthy middle-aged subjects (age 4060 years). All subjects underwent a thorough physical examination and 12-lead ECG in 19801990 (first population) and in 19911992 (second population). The ECG criteria suggested by the European Society of Cardiology were used to identify subjects with the "Brugada sign". Fifteen (0.61%) subjects in the first population and three subjects in the second population (0.55%) fulfilled the ECG criteria for type 2 or 3 Brugada syndrome, i.e., they had J-point elevation and a saddleback-type ST-segment configuration in the right precordial leads. Type 1 Brugada ECG abnormality (coved ST-segment elevation) was not seen in any subject. No mortality or life-threatening ventricular arrhythmias occurred in either study population during follow-up (19±2 years and 11±1 years, respectively).
Conclusion The benign natural course of the patients with the "Brugada sign" suggests that in asymptomatic subjects without a family history of sudden cardiac death, type 2 or 3 Brugada ECG pattern is a normal variant rather than a specific predictor of life-threatening ventricular arrhythmias.
Key Words: Brugada sign Prevalence Prognosis
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in EHJ:
- Brugada sign: a normal variant or a bad omen? Insights for risk stratification and prognostication
- Ali Oto
EHJ 2004 25: 810-811.[Extract] [FREE Full Text]
This article has been cited by other articles:
![]() |
C. Veltmann, C. Wolpert, F. Sacher, P. Mabo, R. Schimpf, F. Streitner, J. Brade, F. Kyndt, J. Kuschyk, H. Le Marec, et al. Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges Europace, October 1, 2009; 11(10): 1345 - 1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Sinner, A. Pfeufer, S. Perz, E. Schulze-Bahr, G. Monnig, L. Eckardt, B.-M. Beckmann, H.-E. Wichmann, G. Breithardt, G. Steinbeck, et al. Spontaneous Brugada electrocardiogram patterns are rare in the German general population: results from the KORA study Europace, October 1, 2009; 11(10): 1338 - 1344. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Veltmann, C. Wolpert, R. Schimpf, P. Mabo, H. LeMarec, M. Borggrefe, and V. Probst The ajmaline challenge and a strange ECG: reply Europace, October 1, 2009; 11(10): 1406 - 1407. [Full Text] [PDF] |
||||
![]() |
N. P. Sidik, C. N. Quay, F. C. Loh, and L. Y. Chen Prevalence of Brugada sign and syndrome in patients presenting with arrhythmic symptoms at a Heart Rhythm Clinic in Singapore Europace, May 1, 2009; 11(5): 650 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sarkozy, G.-B. Chierchia, G. Paparella, T. Boussy, C. De Asmundis, M. Roos, S. Henkens, L. Kaufman, R. Buyl, R. Brugada, et al. Inferior and Lateral Electrocardiographic Repolarization Abnormalities in Brugada Syndrome Circ Arrhythm Electrophysiol, April 1, 2009; 2(2): 154 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W Dubrey, S. K Kohli, P. A Mehta, and R. Grocott-Mason An unusual case of palpitations BMJ, February 11, 2009; 338(feb11_2): a3087 - a3087. [Full Text] |
||||
![]() |
J. Francis and C. Antzelevitch Atrial Fibrillation and Brugada Syndrome J. Am. Coll. Cardiol., March 25, 2008; 51(12): 1149 - 1153. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Letsas, G. Gavrielatos, M. Efremidis, S. P. Kounas, G. S. Filippatos, A. Sideris, and F. Kardaras Prevalence of Brugada sign in a Greek tertiary hospital population Europace, November 1, 2007; 9(11): 1077 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Babaee Bigi, A. Aslani, and S. Shahrzad Prevalence of Brugada sign in patients presenting with palpitation in southern Iran Europace, April 1, 2007; 9(4): 252 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Meregalli, A. A.M. Wilde, and H. L. Tan Pathophysiological mechanisms of Brugada syndrome: Depolarization disorder, repolarization disorder, or more? Cardiovasc Res, August 15, 2005; 67(3): 367 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Oto Brugada sign: a normal variant or a bad omen? Insights for risk stratification and prognostication Eur. Heart J., May 2, 2004; 25(10): 810 - 811. [Full Text] [PDF] |
||||





